Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In Vitro

Abstract

Alteration in cellular prion protein (PrP C) localization on the cell surface through mediation of the glycosylphosphatidylinositol (GPI) anchor has been reported to dramatically affect the formation and infectivity of its pathological isoform (PrP Sc). A patient with Gerstmann-Sträussler-Scheinker (GSS) syndrome was previously found to have a nonsense heterozygous PrP-Q227X mutation resulting in an anchorless PrP. However, the allelic origin of this anchorless PrP Sc and cellular trafficking of PrP Q227X remain to be determined. Here, we show that PrP Sc in the brain of this GSS patient is mainly composed of the mutant but not wild-type PrP (PrP Wt), suggesting pathological PrP Q227X is incapable of recruiting PrP Wt in vivo. This mutant anchorless protein, however, is able to recruit PrP Wt from humanized transgenic mouse brain but not from autopsied human brain homogenates to produce a protease-resistant PrP Sc-like form in vitro by protein misfolding cyclic amplification (PMCA). To further investigate the characteristics of this mutation, constructs expressing human PrP Q227X or PrP Wt were transfected into neuroblastoma cells (M17). Fractionation of the M17 cells demonstrated that most PrP Wt is recovered in the cell lysate fraction, while most of the mutant PrP Q227X is recovered in the medium fraction, consistent with the results obtained by immunofluorescence microscopy. Two-dimensional gel-electrophoresis and Western blotting showed that cellular PrP Q227X spots clustered at molecular weights of 22-25 kDa with an isoelectric point (pI) of 3.5-5.5, whereas protein spots from the medium are at 18-26 kDa with a pI of 7-10. Our findings suggest that the role of GPI anchor in prion propagation between the anchorless mutant PrP and wildtype PrP relies on the cellular distribution of the protein.

Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease

“…Slowly progressive hereditary autosomal dominant neurodegenerative disease or encephalo(myelo)pathy with multicentric PrP plaques localized in the cerebral and cerebellar cortex and the basal ganglia [70].…”

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges

“…The optimization of 2D-GE for prion-like proteins has offered a straightforward and economical preliminary approach to detect the presence of proteoforms. It can be employed to obtain information about glycosylation, sialylation, presence/absence of GPI-anchor, and differences in post-PK cleavage pattern for PrPSc from brains and cerebrospinal fluid of patients [ 82 , 83 , 84 ]. Similarly, in addition to splice-variants, phosphorylation, acetylation, O-GlcNAcylation of tau proteins have been studied using 2D-GE [ 85 , 86 , 87 ].…”